|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 785 for Fasl

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.025s

Categories

Category: Publication
Type Details Score
Publication
First Author: Takahashi T
Year: 1994
Journal: Int Immunol
Title: Human Fas ligand: gene structure, chromosomal location and species specificity.
Volume: 6
Issue: 10
Pages: 1567-74
Publication
First Author: Wenzel J
Year: 2001
Journal: FEBS Lett
Title: Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor.
Volume: 509
Issue: 2
Pages: 255-62
Publication
First Author: Kirkin V
Year: 2007
Journal: Cell Death Differ
Title: The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells.
Volume: 14
Issue: 9
Pages: 1678-87
Publication
First Author: Yankee TM
Year: 2001
Journal: Proc Natl Acad Sci U S A
Title: CD95/Fas induces cleavage of the GrpL/Gads adaptor and desensitization of antigen receptor signaling.
Volume: 98
Issue: 12
Pages: 6789-93
Publication  
First Author: Svandova E
Year: 2018
Journal: Front Physiol
Title: FasL Modulates Expression of Mmp2 in Osteoblasts.
Volume: 9
Pages: 1314
Publication
First Author: Lynch DH
Year: 1995
Journal: Immunol Today
Title: Fas and FasL in the homeostatic regulation of immune responses.
Volume: 16
Issue: 12
Pages: 569-74
Publication
First Author: Tan S
Year: 2019
Journal: Cell Death Dis
Title: IL-6-driven FasL promotes NF-κBp65/PUMA-mediated apoptosis in portal hypertensive gastropathy.
Volume: 10
Issue: 10
Pages: 748
Publication
First Author: Embree-Ku M
Year: 2002
Journal: Toxicol Pathol
Title: FasL deficiency enhances the development of tumors in p53+/- mice.
Volume: 30
Issue: 6
Pages: 705-13
Publication
First Author: Bernard-Bloch R
Year: 2023
Journal: J Leukoc Biol
Title: Ambivalent role of FasL in murine acute graft-versus-host-disease.
Volume: 114
Issue: 3
Pages: 205-211
Publication  
First Author: Apaza Alccayhuaman KA
Year: 2021
Journal: Front Immunol
Title: FasL Is Required for Osseous Healing in Extraction Sockets in Mice.
Volume: 12
Pages: 678873
Publication
First Author: He JS
Year: 2007
Journal: J Immunol
Title: CTLs contain and use intracellular stores of FasL distinct from cytolytic granules.
Volume: 179
Issue: 4
Pages: 2339-48
Publication
First Author: Semkova I
Year: 2006
Journal: FASEB J
Title: Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization.
Volume: 20
Issue: 10
Pages: 1689-91
Publication
First Author: Lau HT
Year: 1996
Journal: Science
Title: Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice.
Volume: 273
Issue: 5271
Pages: 109-12
Publication
First Author: Wang X
Year: 2006
Journal: Cell Death Differ
Title: Activation of extracellular signal-regulated protein kinase 5 downregulates FasL upon osmotic stress.
Volume: 13
Issue: 12
Pages: 2099-108
Publication
First Author: Wang CC
Year: 2006
Journal: Biochem Biophys Res Commun
Title: Mouse lymphomas caused by an intron-splicing donor site deletion of the FasL gene.
Volume: 349
Issue: 1
Pages: 50-8
Publication
First Author: Schulte M
Year: 2007
Journal: Cell Death Differ
Title: ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death.
Volume: 14
Issue: 5
Pages: 1040-9
Publication
First Author: Sato A
Year: 2014
Journal: PLoS One
Title: Involvement of the TNF and FasL produced by CD11b Kupffer cells/macrophages in CCl4-induced acute hepatic injury.
Volume: 9
Issue: 3
Pages: e92515
Publication
First Author: O'Reilly LA
Year: 2015
Journal: Cell Death Differ
Title: Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.
Volume: 22
Issue: 5
Pages: 767-78
Publication
First Author: Fujikura D
Year: 2013
Journal: PLoS One
Title: Type-I interferon is critical for FasL expression on lung cells to determine the severity of influenza.
Volume: 8
Issue: 2
Pages: e55321
Publication
First Author: Cohen PY
Year: 2009
Journal: Am J Respir Cell Mol Biol
Title: Thy1 up-regulates FasL expression in lung myofibroblasts via Src family kinases.
Volume: 40
Issue: 2
Pages: 231-8
Publication
First Author: Embree-Ku M
Year: 2002
Journal: Exp Biol Med (Maywood)
Title: Absence of p53 and FasL has sexually dimorphic effects on both development and reproduction.
Volume: 227
Issue: 7
Pages: 545-53
Publication
First Author: Yao PL
Year: 2007
Journal: J Biol Chem
Title: Transcriptional regulation of FasL expression and participation of sTNF-alpha in response to sertoli cell injury.
Volume: 282
Issue: 8
Pages: 5420-31
Publication
First Author: Shanker A
Year: 2015
Journal: Cancer Res
Title: Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity.
Volume: 75
Issue: 24
Pages: 5260-72
Publication
First Author: Legge KL
Year: 2005
Journal: Immunity
Title: Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression.
Volume: 23
Issue: 6
Pages: 649-59
Publication
First Author: Gorbachev AV
Year: 2010
Journal: Eur J Immunol
Title: CD4+CD25+ regulatory T cells utilize FasL as a mechanism to restrict DC priming functions in cutaneous immune responses.
Volume: 40
Issue: 7
Pages: 2006-15
Publication
First Author: Mohamood AS
Year: 2007
Journal: Am J Pathol
Title: Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.
Volume: 171
Issue: 1
Pages: 97-106
Publication
First Author: Lin YC
Year: 2010
Journal: Toxicol Sci
Title: FasL gene-deficient mice display a limited disruption in spermatogenesis and inhibition of mono-(2-ethylhexyl) phthalate-induced germ cell apoptosis.
Volume: 114
Issue: 2
Pages: 335-45
Publication
First Author: Hornick EE
Year: 2019
Journal: J Clin Invest
Title: Dendritic cell NLRC4 regulates influenza A virus-specific CD4 T cell responses through FasL expression.
Volume: 129
Issue: 7
Pages: 2888-2897
Publication
First Author: Chung CS
Year: 2001
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated.
Volume: 280
Issue: 5
Pages: G812-8
Publication
First Author: Schmidt M
Year: 2016
Journal: J Invest Dermatol
Title: Thy-1/β3 Integrin Interaction-Induced Apoptosis of Dermal Fibroblasts Is Mediated by Up-Regulation of FasL Expression.
Volume: 136
Issue: 2
Pages: 526-529
Publication
First Author: Villa-Morales M
Year: 2010
Journal: Carcinogenesis
Title: Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility.
Volume: 31
Issue: 12
Pages: 2165-71
Publication  
First Author: Soloviova K
Year: 2018
Journal: Clin Immunol
Title: Both perforin and FasL are required for optimal CD8 T cell control of autoreactive B cells and autoantibody production in parent-into-F1 lupus mice.
Volume: 194
Pages: 34-42
Publication
First Author: Nagata S
Year: 1995
Journal: Science
Title: The Fas death factor.
Volume: 267
Issue: 5203
Pages: 1449-56
Publication
First Author: Zhu B
Year: 2000
Journal: Eur J Immunol
Title: Double mutant MRL-lpr/lpr-gld/gld cells fail to trigger lpr-graft-versus-host disease in syngeneic wild-type recipient mice, but can induce wild-type B cells to make autoantibody.
Volume: 30
Issue: 6
Pages: 1778-84
Publication
First Author: Takahashi T
Year: 1994
Journal: Cell
Title: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
Volume: 76
Issue: 6
Pages: 969-76
Publication
First Author: Hahne M
Year: 1995
Journal: Int Immunol
Title: Characterization of the non-functional Fas ligand of gld mice.
Volume: 7
Issue: 9
Pages: 1381-6
Publication
First Author: Dittel BN
Year: 1999
Journal: J Immunol
Title: Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis.
Volume: 162
Issue: 11
Pages: 6392-400
Publication  
First Author: Mustafa N
Year: 2021
Journal: Int J Mol Sci
Title: E2f2 Attenuates Apoptosis of Activated T Lymphocytes and Protects from Immune-Mediated Injury through Repression of Fas and FasL.
Volume: 23
Issue: 1
Publication
First Author: Figgett WA
Year: 2013
Journal: Immunity
Title: The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death.
Volume: 39
Issue: 3
Pages: 573-83
Publication
First Author: Mabrouk I
Year: 2008
Journal: Immunity
Title: Prevention of autoimmunity and control of recall response to exogenous antigen by Fas death receptor ligand expression on T cells.
Volume: 29
Issue: 6
Pages: 922-33
Publication
First Author: Gregory MS
Year: 2011
Journal: PLoS One
Title: Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death.
Volume: 6
Issue: 3
Pages: e17659
Publication
First Author: Karray S
Year: 2004
Journal: J Immunol
Title: Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele.
Volume: 172
Issue: 4
Pages: 2118-25
Publication
First Author: Couillard M
Year: 2002
Journal: Cancer Res
Title: c-myc-induced apoptosis in polycystic kidney disease is independent of FasL/Fas interaction.
Volume: 62
Issue: 8
Pages: 2210-4
Publication
First Author: Petri S
Year: 2006
Journal: J Neurol Sci
Title: Loss of Fas ligand-function improves survival in G93A-transgenic ALS mice.
Volume: 251
Issue: 1-2
Pages: 44-9
Publication
First Author: Weih F
Year: 1996
Journal: Proc Natl Acad Sci U S A
Title: Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway.
Volume: 93
Issue: 11
Pages: 5533-8
Publication
First Author: Sata M
Year: 2000
Journal: J Mol Cell Cardiol
Title: Fas ligand-deficient mice display enhanced leukocyte infiltration and intima hyperplasia in flow-restricted vessels.
Volume: 32
Issue: 8
Pages: 1395-400
Publication
First Author: Langlois RA
Year: 2010
Journal: J Immunol
Title: Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells.
Volume: 184
Issue: 8
Pages: 4440-6
Publication
First Author: Hägglöf T
Year: 2016
Journal: Nat Immunol
Title: Neutrophils license iNKT cells to regulate self-reactive mouse B cell responses.
Volume: 17
Issue: 12
Pages: 1407-1414
Publication
First Author: Crawford HC
Year: 2002
Journal: J Clin Invest
Title: Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.
Volume: 109
Issue: 11
Pages: 1437-44
Publication
First Author: Waldner H
Year: 1997
Journal: J Immunol
Title: Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis.
Volume: 159
Issue: 7
Pages: 3100-3
Publication
First Author: Hahne M
Year: 1996
Journal: Eur J Immunol
Title: Activated B cells express functional Fas ligand.
Volume: 26
Issue: 3
Pages: 721-4
Publication
First Author: Barreiro R
Year: 2004
Journal: J Immunol
Title: Termination of antigen-specific immunity by CD95 ligand (Fas ligand) and IL-10.
Volume: 173
Issue: 3
Pages: 1519-25
Publication
First Author: Hoek RM
Year: 1997
Journal: J Immunol Methods
Title: Allele-specific PCR analysis for detection of the gld Fas-ligand point mutation.
Volume: 210
Issue: 1
Pages: 109-12
Publication
First Author: Potter CS
Year: 2017
Journal: Exp Dermatol
Title: Loss of FAS/FASL signalling does not reduce apoptosis in Sharpin null mice.
Volume: 26
Issue: 9
Pages: 820-822
Publication
First Author: Tsutsui H
Year: 1999
Journal: Immunity
Title: Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice.
Volume: 11
Issue: 3
Pages: 359-67
Publication
First Author: Kaplan HJ
Year: 1999
Journal: Nat Med
Title: Fas ligand (CD95 ligand) controls angiogenesis beneath the retina.
Volume: 5
Issue: 3
Pages: 292-7
Publication
First Author: Huang X
Year: 2011
Journal: J Dent Res
Title: Tgf-beta-mediated FasL-Fas-Caspase pathway is crucial during palatogenesis.
Volume: 90
Issue: 8
Pages: 981-7
Publication
First Author: Hill RA
Year: 2007
Journal: Mol Cell Neurosci
Title: Fas/FasL-mediated apoptosis in the arcuate nucleus and medial preoptic area of male ArKO mice is ameliorated by selective estrogen receptor alpha and estrogen receptor beta agonist treatment, respectively.
Volume: 36
Issue: 2
Pages: 146-57
Publication
First Author: Kong S
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: Endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls B-cell immunity through degradation of the death receptor CD95/Fas.
Volume: 113
Issue: 37
Pages: 10394-9
Publication
First Author: Jonsson H
Year: 2005
Journal: Nat Med
Title: Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis.
Volume: 11
Issue: 6
Pages: 666-71
Publication
First Author: Arai H
Year: 1997
Journal: Proc Natl Acad Sci U S A
Title: Gene transfer of Fas ligand induces tumor regression in vivo.
Volume: 94
Issue: 25
Pages: 13862-7
Publication
First Author: Matsui K
Year: 1998
Journal: J Immunol
Title: Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma.
Volume: 161
Issue: 7
Pages: 3469-73
Publication
First Author: Bonfoco E
Year: 1998
Journal: Immunity
Title: Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells.
Volume: 9
Issue: 5
Pages: 711-20
Publication
First Author: Xiao S
Year: 2004
Journal: J Immunol
Title: Novel negative regulator of expression in Fas ligand (CD178) cytoplasmic tail: evidence for translational regulation and against Fas ligand retention in secretory lysosomes.
Volume: 173
Issue: 8
Pages: 5095-102
Publication
First Author: Sun M
Year: 2006
Journal: J Immunol
Title: The cytoplasmic domain of Fas ligand costimulates TCR signals.
Volume: 177
Issue: 3
Pages: 1481-91
Publication
First Author: Hassin D
Year: 2011
Journal: Immunology
Title: Cytotoxic T lymphocyte perforin and Fas ligand working in concert even when Fas ligand lytic action is still not detectable.
Volume: 133
Issue: 2
Pages: 190-6
Publication
First Author: Kidoya H
Year: 2005
Journal: J Immunol
Title: Fas ligand induces cell-autonomous IL-23 production in dendritic cells, a mechanism for Fas ligand-induced IL-17 production.
Volume: 175
Issue: 12
Pages: 8024-31
Publication
First Author: Villa-Morales M
Year: 2007
Journal: Cancer Res
Title: A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas.
Volume: 67
Issue: 11
Pages: 5107-16
Publication
First Author: Lynch DH
Year: 1994
Journal: Immunity
Title: The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster.
Volume: 1
Issue: 2
Pages: 131-6
Publication
First Author: Ayroldi E
Year: 1999
Journal: Blood
Title: Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene.
Volume: 94
Issue: 10
Pages: 3456-67
Publication
First Author: O' Reilly LA
Year: 2009
Journal: Nature
Title: Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
Volume: 461
Issue: 7264
Pages: 659-63
Publication
First Author: Kayagaki N
Year: 1997
Journal: Proc Natl Acad Sci U S A
Title: Polymorphism of murine Fas ligand that affects the biological activity.
Volume: 94
Issue: 8
Pages: 3914-9
Publication
First Author: Baum PR
Year: 1994
Journal: EMBO J
Title: Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34.
Volume: 13
Issue: 17
Pages: 3992-4001
Publication
First Author: Kehren J
Year: 1999
Journal: J Exp Med
Title: Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity.
Volume: 189
Issue: 5
Pages: 779-86
Publication
First Author: Shanker A
Year: 2009
Journal: Cancer Res
Title: Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity.
Volume: 69
Issue: 16
Pages: 6615-23
Publication
First Author: Schleicher RI
Year: 2015
Journal: Blood
Title: Platelets induce apoptosis via membrane-bound FasL.
Volume: 126
Issue: 12
Pages: 1483-93
Publication
First Author: Krum SA
Year: 2008
Journal: EMBO J
Title: Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival.
Volume: 27
Issue: 3
Pages: 535-45
Publication
First Author: Hao Z
Year: 2004
Journal: J Exp Med
Title: T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis.
Volume: 199
Issue: 10
Pages: 1355-65
Publication
First Author: Brochard V
Year: 2009
Journal: J Clin Invest
Title: Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.
Volume: 119
Issue: 1
Pages: 182-92
Publication
First Author: Wang L
Year: 2015
Journal: Cell Death Differ
Title: Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.
Volume: 22
Issue: 10
Pages: 1654-64
Publication
First Author: Raoul C
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL.
Volume: 103
Issue: 15
Pages: 6007-12
Publication
First Author: Chen C
Year: 2014
Journal: EMBO Mol Med
Title: Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression.
Volume: 6
Issue: 3
Pages: 322-34
Publication
First Author: Qi CF
Year: 2007
Journal: Cancer Res
Title: Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
Volume: 67
Issue: 6
Pages: 2439-47
Publication
First Author: Xu X
Year: 2012
Journal: J Immunol
Title: Splenic stroma-educated regulatory dendritic cells induce apoptosis of activated CD4 T cells via Fas ligand-enhanced IFN-γ and nitric oxide.
Volume: 188
Issue: 3
Pages: 1168-77
Publication
First Author: Bossaller L
Year: 2013
Journal: J Immunol
Title: Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus.
Volume: 191
Issue: 5
Pages: 2104-14
Publication
First Author: Lückerath K
Year: 2011
Journal: Blood
Title: Immune modulation by Fas ligand reverse signaling: lymphocyte proliferation is attenuated by the intracellular Fas ligand domain.
Volume: 117
Issue: 2
Pages: 519-29
Publication
First Author: Zhang JQ
Year: 2004
Journal: J Exp Med
Title: Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in Fasl.
Volume: 200
Issue: 11
Pages: 1467-78
Publication
First Author: Klatt C
Year: 2018
Journal: J Clin Invest
Title: Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis.
Volume: 128
Issue: 9
Pages: 3906-3925
Publication
First Author: Wang X
Year: 2013
Journal: Eur J Immunol
Title: Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis.
Volume: 43
Issue: 1
Pages: 115-24
Publication  
First Author: Trivedi PM
Year: 2019
Journal: Cell Death Discov
Title: Soluble FAS ligand is not required for pancreatic islet inflammation or beta-cell destruction in non-obese diabetic mice.
Volume: 5
Pages: 136
Publication
First Author: Xiao B
Year: 2019
Journal: Biol Reprod
Title: Restraint stress of male mice induces apoptosis in spermatozoa and spermatogenic cells: role of the FasL/Fas system†.
Volume: 101
Issue: 1
Pages: 235-247
Publication
First Author: Morris JE
Year: 2012
Journal: J Immunol
Title: Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1.
Volume: 188
Issue: 2
Pages: 793-9
Publication
First Author: Fullerton AM
Year: 2013
Journal: Toxicol Appl Pharmacol
Title: 2,3,7,8-TCDD enhances the sensitivity of mice to concanavalin A immune-mediated liver injury.
Volume: 266
Issue: 2
Pages: 317-27
Publication
First Author: Cretney E
Year: 2008
Journal: Int Immunol
Title: No requirement for TRAIL in intrathymic negative selection.
Volume: 20
Issue: 2
Pages: 267-76
Publication
First Author: Weintraub JP
Year: 1997
Journal: J Immunol
Title: Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice.
Volume: 159
Issue: 8
Pages: 4117-26
Publication
First Author: Fields ML
Year: 2005
Journal: J Immunol
Title: The influence of effector T cells and Fas ligand on lupus-associated B cells.
Volume: 175
Issue: 1
Pages: 104-11
Publication
First Author: Camacho IA
Year: 2005
Journal: J Immunol
Title: Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of Fas ligand in thymic stromal cells and consequent apoptosis in T cells.
Volume: 175
Issue: 1
Pages: 90-103
Publication
First Author: Krzyzowska M
Year: 2013
Journal: PLoS One
Title: HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway.
Volume: 8
Issue: 7
Pages: e70308
Publication
First Author: Cheng LE
Year: 1997
Journal: EMBO J
Title: Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis.
Volume: 16
Issue: 8
Pages: 1865-75
Publication
First Author: Olson MR
Year: 2009
Journal: J Immunol
Title: Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease.
Volume: 182
Issue: 5
Pages: 3024-31